Deutsche Bank AG London Post Stabilisation Notice - GlaxoSmithKline (0559Q)

TIDMAG99

RNS Number : 0559Q

Deutsche Bank AG London

16 October 2019

16-Oct-19

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in

which such distribution would be unlawful.

GlaxoSmithKline Capital plc

Post-stabilisation Period Announcement

Further to the pre-stabilisation period announcement dated 16/09/2019(1) Deutsche Bank AG London (contact: DCM Syndication TA; telephone: [phone] hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/596/2014) or the rules of the Financial Conduct Authority)(2) was undertaken by the Stabilisation Manager(s)(3) named below in relation to the offer of the following securities.

The Securities:

Issuer: GlaxoSmithKline Capital plc

   Guarantor (if any):                                                           GlaxoSmithKline plc 
   Aggregate nominal amount:                                          EUR 2.5bn 

Description: GlaxoSmithKline EUR 2y FRN and 2/4y FXD

   Stabilisation Manager(s):                                                  BNPP, CS, DB, MS 

Offer Price: 100.650 / 100.289 / 100.184

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

STACKADNFBDKOKD

(END) Dow Jones Newswires

October 16, 2019 04:43 ET (08:43 GMT)